NCT00894413View on ClinicalTrials.gov

A Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

May 8, 2007

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
DRUG

Tadalafil

20 mg once daily for 10 - 14 days

OTHER

Placebo Pill

Placebo

Trial Locations (1)

21205

Johns Hopkins Hospital, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00894413 - A Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract | Biotech Hunter | Biotech Hunter